Medicine guide

EMCITATE

As listed in the register: EMCITATE 350 microgrammes, comprimé dispersible

350 microgrammes · comprimé dispersible

  • Prescription only
Active substance
Tiratricol
Made by
RARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

Details

Made byRARE THYROID THERAPEUTICS INTERNATIONAL AB (SUEDE)
Active substanceTiratricol
Strength350 microgrammes
Formcomprimé dispersible
Routeorale
Dispensing (as stated by the register)prescription réservée aux spécialistes et services NEUROLOGIE · prescription réservée aux spécialistes et services PEDIATRIE · médicament nécessitant une surveillance particulière pendant le traitement · prescription hospitalière · liste I · prescription réservée aux spécialistes et services GENETIQUE MEDICALE · prescription réservée aux spécialistes en ENDOCRINOLOGIE - DIABETOLOGIE - NUTRITION
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/24/1897
Name in the registerEMCITATE 350 microgrammes, comprimé dispersible
Packsplaquette(s) PVC aluminium de 60 comprimé(s)
CIS68773605
CIP133400930310700

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).